TWST: Twist Bioscience Inc Net earnings per share (EPS TTM)
Attracting top biologists and IT experts through generous stock options creates a powerful intellectual foundation for Twist Bioscience (TWST). The company's patented silicon technology for low-cost DNA synthesis ensures its leadership in the pharmaceutical sector, while high B2B customer loyalty guarantees organic growth. The annual net income per share trend visualizes this dynamics, where -2.20 reflects the baseline level of the metric.
Metric breakdowns and analytics for Twist Bioscience Inc (TWST)
- share price and expert price forecast:
- market capitalization information:
- business book valuation details:
- company total debt and liquidity indicators:
Debt to Equity Twist Bioscience|TWST - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital Twist Bio|TWST - Company Total Debt|Debts to Book Capitalization Twist Bioscience, Inc.|TWST - Long-Term Debt Volume|Company Short-Term Debts Twist Bioscience|Quick Liquidity twistbioscience.com
- net income and valuation multiples indicators:
TWST - Company Profit|Projected Future Earnings Twist Bioscience|TWST - Price to Earnings Ratio|Forward P/E Multiple Twist Bioscience, Inc.|TWST - Price to Earnings Adjusted for Growth Rate|Enterprise Value to EBITDA Ratio Twist Bioscience, Inc.|TWST - Company profit before taxes, interest and amortization|Net earnings per share for the last 12 months Twist Bioscience|TWST - Net earnings per share for the last 12 months|Year-over-year earnings per share growth for the last twelve months twistbioscience.com|TWST - Expected net earnings per share growth this year|Expected earnings per share growth for next year Twist Bioscience
Initial company analysis:Twist Bioscience (TWST)
Twist Bioscience (TWST) proprietary robotic DNA synthesis plants ensure production stability, directly impacting the business's bottom-line profitability. By analyzing the net income per share TTM, an investor assesses the actual annual earnings per share, which allows for the verification of the issuer's financial stability and eliminates the risk of unjustified expectations in the presence of leveraged capital.
Competitors of Twist Bioscience
TEM: Net earnings per share for the last 12 months|Earnings per share for the trailing year QGEN (qiagen.com)|IONS: Net earnings per share (EPS TTM)|RGEN (Repligen Corp) - Earnings per share for the last twelve months|RNA (Avidity) - Net earnings per share (EPS TTM)|CRISPR (CRSP) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months GeneDx Holdings Corp. (WGS)|RARE - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Beam Therapeutics BEAM|Net earnings per share for the last four quarters Sarepta Therapeutics (SRPT)|10x Genomics Corp - Net earnings per share (EPS TTM)|Intellia Corp (NTLA) - Net earnings per share for the last 12 months|STOK: Net earnings per share (EPS TTM)|BLFS - Net earnings per share for the last four quarters|WVE (Wave Life Sciences Ltd.) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Maze Therapeutics, Inc. MAZE|Earnings per share for the last twelve months Sionna Pharma (SION)|Prime Medicine Bio - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) TSHA (Taysha Gene Therapies)|QURE - Net earnings per share for the last 12 months|MeiraGTx - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months REGENXBIO Inc|SLDB (Solid Bio) - Net earnings per share for the last 12 months|OCGN: Earnings per share for the last four quarters|Net earnings per share for the last 12 months PACB|Net earnings per share for the last 12 months benitec.com (BNTC)|Earnings per share for the last twelve months Design Therapeutics, Inc. (DSGN)|Net earnings per share for the last four quarters Rocket Pharma|4D Molecular Therapeutics Inc - Net earnings per share for the last 12 months|Earnings per share for the last four quarters LXEO (Lexeo Therapeutics Inc.)|Korro Bio, Inc - Net earnings per share (EPS TTM)|EDIT (editasmedicine.com) - Earnings per share for the last 12 months|Silence Therapeutics plc (SLN) - Earnings per share for the last twelve months|Earnings per share for the last 12 months PRQR|CDXS (Codexis Inc) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Sangamo BioSciences|Net earnings per share for the last 12 months NAUT (Nautilus Biotechnology)|Earnings per share for the last four quarters MGX|Precision BioSciences, Inc. - Net earnings per share for the last 12 months|GBIO - Net earnings per share for the last 12 months|Boundless Bio, Inc - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Exicure, Inc. XCUR|imunon.com (IMNN) - Earnings per share for the last twelve months|PHIO - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months MBIO|RNAZ (TransCode) - Earnings per share for the last four quarters|Net earnings per share for the last 12 months BNGO (Bionano Genomics, Inc.)|APDN (Applied DNA Corp) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) BLUE (bluebird bio, Inc.)|ImmunoPrecise Antibodies Ltd - Earnings per share for the last twelve months|Omega Therapeutics, Inc. - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Singular Genomics Systems, Inc. OMIC|Regulus Therapeutics Inc (RGLS) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Syros Pharmaceuticals, Inc (SYRS)|Earnings per share for the last twelve months Telesis Bio, Inc.|traconpharma.com (TCON) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) UBX
